When:
Wednesday, Feb 28, 2018 8:30a -
11:30a

Where:
MassBio
300
Cambridge, Massachusetts 02139

Admission:
FREE

Categories:
Business, Innovation, Lectures & Conferences, Tech

Event website:
http://events.r20.constantcontact.com/register/event?llr=l7sugnyab&oeidk=a07ef3wgg821c4496e7

Join academic, clinical, technology development and research stakeholders for a dialogue about emerging opportunities to treat hearing loss with therapeutics as well as new approaches for discovery, testing and treatment with the potential to rapidly accelerate therapeutic development.

Register by Feb. 27, 2018

Panelists and Themes
- Clinical and surgical perspective - Dr. Daniel J. Lee, M.D., ENT Surgeon, Massachusetts Eye and Ear Infirmary; Associate Professor, Harvard Medical School
- Patient perspective - Annahita Forghan, cochlear implant patient and PharmD student candidate
- Research perspective - Dr. David P. Corey, Ph.D., Bertarelli Professor of Translational Medical Science, Harvard Medical School -
- Preclinical model and efficacy assessment - Celia Belline, CEO, CILcare
- Safety assessment and combination product perspective - Peter M. Markham, CEO, CBSET
- Intracochlear Drug Delivery device (ICDD) - Dr. Jeffrey T. Borenstein, Ph.D., Draper Biomedical and Tissue Engineering

For more program information, see https://www.massbio.org/events/advancing-solutions-in-hearing-loss-program-2603.

Share this event

Add to:

28/02/2018 08:30:00 28/02/2018 11:30:00 15 Advancing Solutions in Hearing Loss Join academic, clinical, technology development and research stakeholders for a dialogue about emerging opportunities to treat hearing loss with therapeutics as well as new approaches for discovery... MassBio, Cambridge, Massachusetts 02139 Organizer Organizer e-mail false DD/MM/YYYY Reddit